Key result
Wearable ECG demonstrates excellent reliability vs. standard 12-lead ECG, matching heart rate at ~0.93 ICC.
Why the study?
The clinical utility of a wearable ECG device (HEH) compared with a standard 12-lead ECG device (FX) in Korean medicine practice required evaluation of measurement reliability and agreement.
Does a wearable ECG device (HEH) provide reliable and agreeable ECG measurements compared to a standard 12-lead ECG in adult patients?
Cross-Sectional (n=94)
Open-label
Balanced block randomization (for measurement sequence)
No
Does a wearable ECG device (HEH) provide reliable and agreeable ECG measurements compared to a standard 12-lead ECG in adult patients?
Effect estimate: ICC 0.933 (95% CI 0.905-0.956)
The HEH wearable ECG device demonstrates high reliability and agreement comparable to a standard 12-lead ECG, indicating its potential validity for continuous, long-term cardiac monitoring.
May support wearable ECG monitoring; extends validation criteria but leaves open prospective outcome trials.
Objectives: This study aimed to evaluate the measurement reliability and agreement of a wearable electrocardiogram (ECG) device (HEH) compared with a standard 12-lead ECG device (FX) to validate its clinical utility in Korean medicine practice.Methods: In a randomized sequential method-comparison study of 94 adults, ECG parameters were sequentially measured using both the HEH and FX devices during a single visit. Primary efficacy variables were heart rate, RR interval, and QRS interval. Secondary efficacy variables were the PR interval, QT interval, QTc interval, and axis. Inter-device reliability and agreement were assessed using the Intraclass Correlation Coefficient (ICC; two-way mixed model, absolute agreement) and Bland-Altman plots. Results: HEH demonstrated excellent reliability for the primary efficacy variables (ICC>0.90) and good reliability for the secondary efficacy variables (ICC>0.87). Bland-Altman analysis revealed that the mean difference was near zero for all variables. The mean difference for heart rate fell within the allowable limits defined by ANSI/AAMI/IEC 60601-2-27:2011. The mean differences for the QRS, PR, and QT intervals fell within the allowable limits defined by the KS C IEC 60601-2-25 CSE study criteria. Axis showed good ICC (0.876) but a relatively higher mean absolute difference (MAD=13.1°).Conclusions: The HEH device demonstrates high reliability and agreement comparable to those of the standard ECG device (FX). These findings suggest that HEH is a valid tool for long-term clinical monitoring and quantitative evaluation of treatment efficacy in Korean medicine.
No takes yet. Share an insight, caveat, or question.
Kwak et al. (2026) conducted a cross-sectional in General adult population (n=94). Wearable ECG device (HEH) vs. Standard 12-lead ECG device (FX) was evaluated on Measurement reliability for heart rate (Intraclass Correlation Coefficient) (ICC 0.933, 95% CI 0.905-0.956). The wearable ECG device demonstrated excellent reliability for primary efficacy variables including heart rate (ICC 0.933), RR interval (ICC 0.938), and QRS interval (ICC 0.900) compared to a standard 12-lead ECG.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: